Franz, D. N., Belousova, E., Sparagana, S., Bebin, E. M., Frost, M., Kuperman, R., . . . Jozwiak, S. (2013). Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): A multicentre, randomised, placebo-controlled phase 3 trial. The lancet, 381(9861), . https://doi.org/10.1016/S0140-6736(12)61134-9
Chicago-Zitierstil (17. Ausg.)Franz, David N., et al. "Efficacy and Safety of Everolimus for Subependymal Giant Cell Astrocytomas Associated with Tuberous Sclerosis Complex (EXIST-1): A Multicentre, Randomised, Placebo-controlled Phase 3 Trial." The Lancet 381, no. 9861 (2013). https://doi.org/10.1016/S0140-6736(12)61134-9.
MLA-Zitierstil (9. Ausg.)Franz, David N., et al. "Efficacy and Safety of Everolimus for Subependymal Giant Cell Astrocytomas Associated with Tuberous Sclerosis Complex (EXIST-1): A Multicentre, Randomised, Placebo-controlled Phase 3 Trial." The Lancet, vol. 381, no. 9861, 2013, https://doi.org/10.1016/S0140-6736(12)61134-9.